[Effect of live tularemia vaccine on the counter-suppression of lymphocytes and the end results of the combined treatment of endometrial cancer].
Starting from stage I-II, patients with endometrial tumors (ET) revealed a significant decline (p < 0.05) in counter-suppression lymphocytes as compared to healthy subjects of the same age. The correlation was particularly marked in cases of stage III-IV tumors (p < 0.01).